[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3771039D1 - Therapeutisches mittel. - Google Patents

Therapeutisches mittel.

Info

Publication number
DE3771039D1
DE3771039D1 DE8787309788T DE3771039T DE3771039D1 DE 3771039 D1 DE3771039 D1 DE 3771039D1 DE 8787309788 T DE8787309788 T DE 8787309788T DE 3771039 T DE3771039 T DE 3771039T DE 3771039 D1 DE3771039 D1 DE 3771039D1
Authority
DE
Germany
Prior art keywords
lower alkyl
therapeutic agent
halo
trifluoromethyl
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787309788T
Other languages
English (en)
Inventor
Roy Victor Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of DE3771039D1 publication Critical patent/DE3771039D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DE8787309788T 1986-11-20 1987-11-05 Therapeutisches mittel. Expired - Fee Related DE3771039D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868627698A GB8627698D0 (en) 1986-11-20 1986-11-20 Therapeutic agents

Publications (1)

Publication Number Publication Date
DE3771039D1 true DE3771039D1 (de) 1991-08-01

Family

ID=10607612

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309788T Expired - Fee Related DE3771039D1 (de) 1986-11-20 1987-11-05 Therapeutisches mittel.

Country Status (24)

Country Link
US (1) US4877793A (de)
EP (1) EP0269295B1 (de)
JP (1) JPS63141984A (de)
KR (1) KR880006247A (de)
CN (1) CN1019491B (de)
AT (1) ATE64736T1 (de)
AU (1) AU599721B2 (de)
DD (1) DD282690A5 (de)
DE (1) DE3771039D1 (de)
DK (1) DK599887A (de)
ES (1) ES2038188T3 (de)
FI (1) FI875020A (de)
GB (1) GB8627698D0 (de)
GR (1) GR3002500T3 (de)
HU (1) HU198060B (de)
IL (1) IL84505A (de)
JO (1) JO1520B1 (de)
MX (1) MX9428A (de)
NO (1) NO874834L (de)
NZ (1) NZ222554A (de)
PH (1) PH23293A (de)
PL (1) PL149617B1 (de)
PT (1) PT86115B (de)
ZA (1) ZA878306B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
ZA903588B (en) * 1989-05-16 1991-02-27 Merrell Dow Pharma Excitatory amino acid antagonists
US5219864A (en) * 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
WO2000007595A1 (en) * 1998-08-03 2000-02-17 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US8329924B2 (en) 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038294A1 (es) 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
KR101058696B1 (ko) 2002-12-10 2011-08-22 바이로켐 파마 인코포레이티드 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법
AP2007004245A0 (en) 2005-05-13 2007-12-31 Virochem Pharma Inc Compounds and methods for the treatment or prevention of flavivirus infections
JP2008093872A (ja) * 2006-10-09 2008-04-24 Kouritsu Kogyo:Kk 表示装置
MX2009005185A (es) 2006-11-15 2009-07-07 Virochem Pharma Inc Analogos de tiofeno para el tratamiento o prevencion de infecciones de flavivirus.
UA103617C2 (ru) * 2008-05-05 2013-11-11 Мерк Патент Гмбх Производные тиенопиридона как активаторы амр-активированной протеинкиназы (амрк)
KR101486693B1 (ko) * 2011-04-27 2015-01-26 바스프 에스이 디티에노피리돈 공중합체 기재의 반도체 물질
AU2018265130B2 (en) * 2017-05-11 2022-03-24 Bristol-Myers Squibb Company Thienopyridines and benzothiophenes useful as IRAK4 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
EP0126970A3 (de) * 1983-04-27 1985-11-06 Beecham Group Plc Anxiolytische und anti-depressante Thienopyridinderivate
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (de) * 1984-01-13 1990-06-27 The Boots Company PLC Verwendung von Chinolonen für die Herstellung eines Arzneimittels zur Behandlung von Herzerkrankungen.
DE3575961D1 (de) * 1984-07-13 1990-03-15 Pandrol Ltd Schienenunterlagen.
EP0172004B1 (de) * 1984-08-15 1990-03-21 The Boots Company PLC Chinolinone, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Präparate
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
JPS63141984A (ja) 1988-06-14
ZA878306B (en) 1988-05-02
NO874834L (no) 1988-05-24
PT86115B (pt) 1990-08-31
JO1520B1 (en) 1989-01-25
AU8144087A (en) 1988-05-26
MX9428A (es) 1993-10-01
DK599887A (da) 1988-05-21
HU198060B (en) 1989-07-28
PL268925A1 (en) 1988-09-01
FI875020A0 (fi) 1987-11-13
PL149617B1 (en) 1990-03-31
DD282690A5 (de) 1990-09-19
PH23293A (en) 1989-06-30
PT86115A (en) 1987-12-01
IL84505A (en) 1990-12-23
EP0269295B1 (de) 1991-06-26
ATE64736T1 (de) 1991-07-15
HUT47289A (en) 1989-02-28
GR3002500T3 (en) 1992-12-30
DK599887D0 (da) 1987-11-16
EP0269295A1 (de) 1988-06-01
AU599721B2 (en) 1990-07-26
CN87107975A (zh) 1988-06-01
GB8627698D0 (en) 1986-12-17
KR880006247A (ko) 1988-07-22
NZ222554A (en) 1989-08-29
ES2038188T3 (es) 1993-07-16
US4877793A (en) 1989-10-31
FI875020A (fi) 1988-05-21
CN1019491B (zh) 1992-12-16
NO874834D0 (no) 1987-11-19

Similar Documents

Publication Publication Date Title
ATE64736T1 (de) Therapeutisches mittel.
MA21502A1 (fr) 4--phenyl-(-piperazinyl)phenols et procedes pour leur preparation .
MY102086A (en) Imidazoquinoline derivatives.
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
IE872588L (en) Compounds
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ATE60596T1 (de) Entzuendung verhindernde und allergie heilende mittel.
HUT53886A (en) Fungicide preparations containing propencarboxylic acid derivatives as agents and process for producing the agents
IL99305A (en) 4-substituted dihydropyrido [4,3-d]pyrimidines their preparation and analgesic and topical antiinflammatory compositions containing them for the treatment of skin disorders
FI893901A (fi) Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
DK0402033T3 (da) Carboxamidderivater
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ZA872925B (en) Heterocyclic compounds
DE3778088D1 (de) Substituierte pyrimidochinoxaline.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee